Recovery of high value Proteins from Serum by innovative direct Capture techniques

Project Details


The extraction of biopharmaceuticals from natural sources often employs overly complicated antiquated procedures. The downstream processing of serum is a case in point; it comprises large numbers of steps of low purification power and consequently delivers poor overall product yields.
Parallel advances in magnetic separation equipment and approaches to manufacture magnetic affinity particles, funded through several national and EU funded projects lay the foundations for the proposed work. Using magnetic bioseparation techniques, the consortium will seek to replace outdated organic solvent based fractionation methods, which can inflict serious damage on especially prone protein targets.
In ProSeCa, our combined expertise will be applied to the production of protein based veterinary medicines from horse sera, centring on harmonious integrated use of: highly selective magnetic adsorbents manufactured via: (i) chemical; (ii) biological; and (iii) mixed ‘biological/chemical’ routes; with a fully automated and cGMP compliant magnetic separator.
Effective start/end date01/03/201428/02/2017

Collaborative partners

  • Technical University of Denmark (lead)
  • Senova GmbH (Project partner)
  • Karlsruhe Institute of Technology (Project partner)
  • Fertigungszentrum Mashinenbau GmbH (Project partner)
  • University of Birmingham (Project partner)


  • European Commission- European Research Area


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.